BioMedica Logo
Genetics

Genomic Biomarkers in Precision Oncology

Biomarker-driven care is reshaping treatment planning for cancer patients.

Dr. Sarah AhmedDr. Sarah Ahmed
May 8, 2026
10 min read
730 views
Dr. Sarah Ahmed

Dr. Sarah Ahmed

Associate Professor, Department of Biomedical Engineering

University of Toronto, Canada

Dr. Sarah Ahmed's research focuses on medical image analysis, machine learning applications in healthcare, and computer vision.
View Profile

Abstract

Genomic biomarkers improve therapeutic precision in oncology care.

1. Introduction

Precision oncology depends on identifying actionable mutations and translating them into treatment pathways.

2. Clinical Utility

Biomarkers enable patient stratification and more targeted therapy matching.
  • Targeted therapy matching
  • Resistance monitoring
  • Companion diagnostics

3. Implementation Barriers

Turnaround time, reimbursement, and interpretation complexity remain common obstacles.

4. Future Directions

Multimodal data integration and better real-world evidence pipelines may improve adoption.

5. Conclusion

Genomic biomarkers support more personalized cancer care when interpretation is robust.

References

  1. Genomics reference 1
  2. Genomics reference 2
  3. Genomics reference 3
View on PubMedDOI: 10.1000/genetics1Download PDF
Tags:GenomicsOncologyBiomarkers
Share:

Discussion (0)

Join the conversation
* Name and comment are required
No discussions yet. Be the first to share your thoughts!